TY  - GEN
AU  - Park,Jin Joo
AU  - Park,Kyung Woo
AU  - Kang,Jeehoon
AU  - Jeon,Ki-Hyun
AU  - Kang,Si-Hyuck
AU  - Ahn,Hyo Suk
AU  - Han,Jung-Kyu
AU  - Koh,Jin-Sin
AU  - Lee,Sang Eun
AU  - Yang,Han-Mo
AU  - Lee,Hae-Young
AU  - Kang,Hyun-Jae
AU  - Koo,Bon-Kwon
AU  - Oh,Byung-Hee
AU  - Park,Young-Bae
AU  - Kim,Hyo-Soo
TI  - CYP3A4 genetic status may be associated with increased vulnerability to the inhibitory effect of calcium-channel blockers on clopidogrel
SN  - 1347-4820
PY  - 2013///1031
KW  - Aged
KW  - Blood Platelets
KW  - drug effects
KW  - Calcium Channel Blockers
KW  - therapeutic use
KW  - Chi-Square Distribution
KW  - Clopidogrel
KW  - Cytochrome P-450 CYP3A
KW  - genetics
KW  - Cytochrome P-450 CYP3A Inhibitors
KW  - Drug Interactions
KW  - Enzyme Inhibitors
KW  - Female
KW  - Gene Frequency
KW  - Genotype
KW  - Humans
KW  - Linear Models
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Odds Ratio
KW  - Pharmacogenetics
KW  - Phenotype
KW  - Platelet Aggregation
KW  - Platelet Aggregation Inhibitors
KW  - administration & dosage
KW  - Platelet Function Tests
KW  - Prospective Studies
KW  - Purinergic P2Y Receptor Antagonists
KW  - Receptors, Purinergic P2Y12
KW  - blood
KW  - Risk Factors
KW  - Ticlopidine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1253/circj.cj-12-0682
ER  -